Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (315)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
24
2023
190
12.850
 Why?
Seizures
20
2023
208
5.030
 Why?
Spasms, Infantile
8
2022
30
3.980
 Why?
Anticonvulsants
12
2023
129
3.960
 Why?
Cannabidiol
5
2022
35
3.810
 Why?
Status Epilepticus
6
2021
37
3.660
 Why?
Tuberous Sclerosis
6
2022
37
3.600
 Why?
Mutation
16
2023
1501
3.160
 Why?
Electroencephalography
17
2022
356
2.480
 Why?
Epilepsies, Myoclonic
4
2020
11
2.450
 Why?
Intellectual Disability
5
2023
149
2.390
 Why?
Humans
99
2023
54284
2.340
 Why?
Hemiplegia
3
2021
12
2.230
 Why?
Brain
9
2019
1387
2.150
 Why?
Child
34
2023
7341
1.940
 Why?
Developmental Disabilities
5
2019
127
1.860
 Why?
Epilepsy, Absence
3
2019
11
1.820
 Why?
Magnetic Resonance Imaging
15
2019
1604
1.710
 Why?
Neuroaxonal Dystrophies
2
2022
9
1.550
 Why?
Nervous System Malformations
3
2020
17
1.540
 Why?
Tumor Suppressor Proteins
3
2023
141
1.530
 Why?
Folate Receptor 1
2
2022
24
1.510
 Why?
Epilepsies, Partial
2
2022
13
1.420
 Why?
Infant, Newborn, Diseases
2
2020
64
1.400
 Why?
Ketamine
2
2020
61
1.390
 Why?
Neurocutaneous Syndromes
2
2019
6
1.270
 Why?
Infant
17
2023
3817
1.260
 Why?
Cadherins
2
2019
72
1.240
 Why?
Cerebral Arteries
2
2019
37
1.170
 Why?
Child, Preschool
17
2023
4147
1.160
 Why?
Epilepsy, Generalized
2
2023
11
1.150
 Why?
Sirolimus
2
2017
65
1.130
 Why?
Angiofibroma
2
2015
6
1.090
 Why?
Facial Neoplasms
2
2015
23
1.070
 Why?
Nerve Tissue Proteins
2
2018
199
1.060
 Why?
Valproic Acid
2
2022
32
1.050
 Why?
Stroke
3
2019
526
0.970
 Why?
Pregnanolone
2
2023
6
0.960
 Why?
Male
32
2021
27334
0.910
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.900
 Why?
Female
28
2023
28441
0.890
 Why?
Aphasia
1
2022
28
0.860
 Why?
Quality Improvement
2
2022
245
0.840
 Why?
Nervous System Diseases
2
2021
97
0.830
 Why?
Abnormalities, Multiple
3
2023
159
0.820
 Why?
Chromosome Deletion
3
2019
150
0.820
 Why?
Treatment Outcome
9
2023
5604
0.800
 Why?
Emergencies
1
2021
92
0.790
 Why?
Transition to Adult Care
1
2020
13
0.770
 Why?
Angelman Syndrome
1
2020
2
0.770
 Why?
Pharmaceutical Preparations
1
2021
86
0.770
 Why?
Immunoglobulins, Intravenous
1
2021
55
0.750
 Why?
Bone Diseases, Developmental
2
2023
13
0.750
 Why?
Tooth Abnormalities
2
2023
10
0.750
 Why?
Fenfluramine
1
2020
7
0.740
 Why?
Oligonucleotides, Antisense
1
2020
29
0.740
 Why?
Phenobarbital
1
2020
17
0.740
 Why?
Dioxolanes
1
2020
13
0.730
 Why?
Flunarizine
1
2019
1
0.730
 Why?
Behavioral Symptoms
1
2019
5
0.730
 Why?
Excitatory Amino Acid Antagonists
1
2020
51
0.720
 Why?
Ocular Physiological Phenomena
1
2019
4
0.710
 Why?
Tetrasomy
1
2019
2
0.710
 Why?
Immunologic Factors
1
2021
130
0.710
 Why?
Agenesis of Corpus Callosum
2
2018
9
0.710
 Why?
Chromosomes, Human, Pair 5
1
2019
16
0.710
 Why?
Sneddon Syndrome
1
2019
3
0.710
 Why?
Livedo Reticularis
1
2019
5
0.700
 Why?
Oral Ulcer
1
2019
3
0.700
 Why?
Behcet Syndrome
1
2019
7
0.700
 Why?
Calcium Channel Blockers
1
2019
72
0.700
 Why?
Transposases
1
2019
10
0.690
 Why?
Andersen Syndrome
1
2019
1
0.690
 Why?
Genetic Therapy
1
2020
121
0.690
 Why?
Hydrocephalus
1
2019
41
0.690
 Why?
Receptors, GABA-B
1
2019
12
0.690
 Why?
Vitiligo
1
2019
8
0.690
 Why?
Spinal Cord Diseases
1
2019
37
0.690
 Why?
Nephrotic Syndrome
2
2017
21
0.680
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.680
 Why?
Leukoencephalopathies
1
2019
17
0.680
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
9
0.680
 Why?
Migraine Disorders
2
2020
49
0.670
 Why?
Cannabinoid Receptor Agonists
1
2019
48
0.670
 Why?
Cerebral Infarction
1
2018
32
0.670
 Why?
Muscle Weakness
1
2019
46
0.670
 Why?
Edema
1
2019
74
0.670
 Why?
Electron Transport Complex IV
1
2018
45
0.670
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.660
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.660
 Why?
Shab Potassium Channels
1
2018
2
0.660
 Why?
Optic Atrophy
1
2018
18
0.660
 Why?
Photic Stimulation
1
2018
65
0.660
 Why?
Brain Edema
1
2018
39
0.650
 Why?
Physicians
1
2022
247
0.650
 Why?
Alopecia
1
2019
59
0.650
 Why?
Parents
1
2021
344
0.640
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
29
0.640
 Why?
Myoclonus
1
2018
10
0.640
 Why?
Biomedical Research
1
2021
240
0.630
 Why?
Thrombocytopenia
1
2019
99
0.630
 Why?
Artifacts
1
2018
61
0.630
 Why?
Autoimmune Diseases
1
2019
114
0.620
 Why?
Neurodegenerative Diseases
1
2018
83
0.620
 Why?
Practice Guidelines as Topic
1
2020
492
0.610
 Why?
Osteochondrodysplasias
1
2017
14
0.600
 Why?
Hearing Loss, Sensorineural
1
2018
82
0.600
 Why?
Immunologic Deficiency Syndromes
1
2017
20
0.600
 Why?
Arteriosclerosis
1
2017
59
0.590
 Why?
Carotid Artery Diseases
1
2017
38
0.590
 Why?
Drug Discovery
1
2017
90
0.580
 Why?
Child Development
1
2018
204
0.580
 Why?
Prenatal Exposure Delayed Effects
1
2018
173
0.580
 Why?
Mitochondrial Diseases
1
2018
109
0.580
 Why?
Phenotype
2
2021
820
0.580
 Why?
Health Knowledge, Attitudes, Practice
1
2021
543
0.580
 Why?
Cafe-au-Lait Spots
1
2016
2
0.570
 Why?
Models, Biological
1
2020
823
0.570
 Why?
Erythema Infectiosum
1
2015
3
0.560
 Why?
Migraine with Aura
1
2015
4
0.560
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.560
 Why?
Corpus Callosum
2
2023
28
0.550
 Why?
Williams Syndrome
1
2016
29
0.550
 Why?
Sinus Pericranii
1
2015
1
0.550
 Why?
Adolescent
12
2023
6897
0.550
 Why?
Parvovirus B19, Human
1
2015
17
0.550
 Why?
SOS1 Protein
1
2015
2
0.550
 Why?
Toes
1
2015
19
0.550
 Why?
Crying
1
2015
4
0.550
 Why?
Electrodiagnosis
1
2015
14
0.540
 Why?
Moyamoya Disease
1
2015
8
0.540
 Why?
Iatrogenic Disease
1
2015
24
0.540
 Why?
Hyperventilation
1
2015
8
0.540
 Why?
Pulmonary Embolism
1
2017
106
0.540
 Why?
Tuberculoma
1
2015
3
0.540
 Why?
Infant, Newborn
5
2020
2907
0.540
 Why?
Epilepsy, Benign Neonatal
1
2015
3
0.540
 Why?
Noonan Syndrome
1
2015
12
0.540
 Why?
Skin
1
2019
469
0.530
 Why?
Neurologic Examination
1
2015
76
0.530
 Why?
Encephalitis
1
2016
48
0.530
 Why?
Mutism
1
2015
3
0.530
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.530
 Why?
Ocular Motility Disorders
1
2015
21
0.530
 Why?
Communication
3
2022
273
0.520
 Why?
TOR Serine-Threonine Kinases
1
2015
85
0.520
 Why?
Trisomy
1
2014
34
0.510
 Why?
Repressor Proteins
2
2023
165
0.510
 Why?
Energy Drinks
1
2014
6
0.500
 Why?
Diagnosis, Differential
7
2020
1136
0.500
 Why?
KCNQ2 Potassium Channel
1
2014
18
0.500
 Why?
Neurology
1
2015
46
0.500
 Why?
Syndrome
5
2020
252
0.490
 Why?
Vasoconstriction
1
2014
60
0.490
 Why?
Influenza, Human
1
2015
120
0.490
 Why?
Benzodiazepines
1
2014
72
0.490
 Why?
Osteomyelitis
1
2015
122
0.490
 Why?
Membrane Proteins
1
2016
389
0.460
 Why?
Sleep
1
2014
188
0.460
 Why?
Enzyme Inhibitors
1
2015
446
0.440
 Why?
Magnetic Resonance Angiography
3
2019
80
0.440
 Why?
Immunosuppressive Agents
3
2019
248
0.420
 Why?
Pediatrics
1
2015
323
0.400
 Why?
Quality of Life
3
2022
922
0.380
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
121
0.380
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
126
0.370
 Why?
Caregivers
2
2021
241
0.340
 Why?
Recurrence
3
2019
690
0.340
 Why?
Echinocandins
1
2008
64
0.330
 Why?
Mycoses
1
2008
162
0.300
 Why?
Gastroesophageal Reflux
2
2019
49
0.300
 Why?
Administration, Topical
2
2015
71
0.270
 Why?
Antifungal Agents
1
2008
363
0.270
 Why?
Retrospective Studies
6
2023
6432
0.260
 Why?
Psychosurgery
1
2023
4
0.240
 Why?
Laser Therapy
1
2023
91
0.220
 Why?
Speech Disorders
1
2022
18
0.220
 Why?
Ethosuximide
1
2022
5
0.220
 Why?
Clonazepam
1
2022
5
0.220
 Why?
Electrodes, Implanted
1
2022
29
0.220
 Why?
Stereotaxic Techniques
1
2022
36
0.220
 Why?
Cluster Analysis
1
2023
249
0.220
 Why?
Death, Sudden
1
2022
13
0.220
 Why?
GTPase-Activating Proteins
1
2022
23
0.210
 Why?
Concept Formation
1
2021
11
0.210
 Why?
Freedom
1
2021
3
0.210
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
5
0.210
 Why?
Diazepam
1
2021
18
0.210
 Why?
Folic Acid
1
2022
139
0.200
 Why?
Drug Interactions
1
2022
206
0.200
 Why?
Fibroma
1
2021
41
0.200
 Why?
Adrenocorticotropic Hormone
2
2022
34
0.200
 Why?
Dihydroergotamine
1
2020
5
0.190
 Why?
Personal Satisfaction
1
2021
90
0.190
 Why?
Brain Diseases
1
2021
87
0.190
 Why?
Soft Tissue Neoplasms
1
2021
65
0.190
 Why?
Risk Factors
2
2020
3935
0.190
 Why?
Facies
2
2023
35
0.190
 Why?
Diet Therapy
1
2020
8
0.190
 Why?
Perception
1
2021
143
0.190
 Why?
Genetic Diseases, Inborn
1
2020
26
0.180
 Why?
Qualitative Research
1
2021
331
0.180
 Why?
Consensus
1
2021
157
0.180
 Why?
Ubiquitin-Protein Ligases
1
2020
99
0.180
 Why?
Transcription Factors
2
2023
622
0.180
 Why?
Clinical Protocols
1
2020
122
0.180
 Why?
Anesthetics
1
2020
36
0.180
 Why?
Treatment Failure
1
2020
139
0.180
 Why?
Leukomalacia, Periventricular
1
2019
12
0.180
 Why?
Matrix Attachment Region Binding Proteins
1
2020
31
0.180
 Why?
Muscle Hypotonia
1
2019
24
0.180
 Why?
Chromosomes, Human, Pair 7
1
2019
30
0.180
 Why?
HLA-B51 Antigen
1
2019
2
0.180
 Why?
Craniofacial Abnormalities
1
2019
27
0.170
 Why?
Patient-Centered Care
1
2021
134
0.170
 Why?
Ventriculoperitoneal Shunt
1
2019
28
0.170
 Why?
Learning
1
2021
175
0.170
 Why?
Heart Septal Defects, Atrial
1
2019
45
0.170
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
6
0.170
 Why?
Ventricular Premature Complexes
1
2019
6
0.170
 Why?
Analgesics, Non-Narcotic
1
2020
140
0.170
 Why?
Disease Management
1
2020
184
0.170
 Why?
Microcephaly
1
2019
43
0.170
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.170
 Why?
Facial Nerve Diseases
1
2018
6
0.170
 Why?
Randomized Controlled Trials as Topic
1
2022
596
0.170
 Why?
Syncope
1
2019
30
0.170
 Why?
Nocturnal Myoclonus Syndrome
1
2018
14
0.170
 Why?
Referral and Consultation
1
2021
307
0.170
 Why?
Cerebral Veins
1
2018
16
0.170
 Why?
Facial Paralysis
1
2018
24
0.170
 Why?
Deglutition Disorders
1
2019
71
0.170
 Why?
Anti-Arrhythmia Agents
1
2019
87
0.160
 Why?
Health Personnel
1
2021
246
0.160
 Why?
Frameshift Mutation
1
2018
17
0.160
 Why?
Video Recording
1
2018
90
0.160
 Why?
Acute Disease
1
2019
403
0.160
 Why?
Fatal Outcome
1
2019
225
0.160
 Why?
Adult
4
2023
14207
0.160
 Why?
Fibrinolytic Agents
1
2019
139
0.160
 Why?
Fear
1
2018
87
0.160
 Why?
Combined Modality Therapy
1
2020
692
0.160
 Why?
Anti-Inflammatory Agents
1
2019
175
0.160
 Why?
Clinical Trials as Topic
1
2020
490
0.160
 Why?
India
1
2017
79
0.160
 Why?
History, 21st Century
1
2017
62
0.150
 Why?
Platelet Aggregation Inhibitors
1
2019
180
0.150
 Why?
Cerebellum
1
2018
142
0.150
 Why?
Methotrexate
1
2017
73
0.150
 Why?
History, 20th Century
1
2017
114
0.150
 Why?
Neurotoxicity Syndromes
1
2017
52
0.150
 Why?
Anti-Infective Agents
1
2017
110
0.140
 Why?
Pandemics
1
2021
579
0.140
 Why?
Aldehyde Dehydrogenase
1
2016
27
0.140
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
105
0.140
 Why?
Influenza B virus
1
2015
6
0.140
 Why?
Hormones
1
2016
59
0.140
 Why?
Delayed Diagnosis
1
2016
25
0.140
 Why?
Chromosomes, Human, Pair 3
1
2015
20
0.140
 Why?
North America
1
2015
68
0.140
 Why?
Animals
3
2022
14385
0.140
 Why?
Arkansas
1
2021
2100
0.130
 Why?
Cerebral Angiography
1
2015
106
0.130
 Why?
Chromosomes, Human, Pair 9
1
2014
20
0.130
 Why?
Antibiotics, Antineoplastic
1
2015
85
0.130
 Why?
Brain Waves
1
2014
23
0.130
 Why?
Drug Resistance
1
2015
74
0.130
 Why?
Complementary Therapies
1
2015
31
0.130
 Why?
Antiemetics
1
2014
35
0.120
 Why?
Headache
1
2014
78
0.120
 Why?
Vomiting
1
2014
73
0.120
 Why?
Mutation, Missense
1
2014
117
0.120
 Why?
Glutamine
1
2015
168
0.120
 Why?
Polymerase Chain Reaction
1
2015
531
0.120
 Why?
Arginine
1
2015
182
0.120
 Why?
Decision Making, Computer-Assisted
1
2013
5
0.120
 Why?
Analgesics
1
2014
106
0.120
 Why?
Vigabatrin
2
2022
2
0.110
 Why?
Diagnostic Errors
1
2013
74
0.110
 Why?
Evidence-Based Medicine
1
2013
281
0.100
 Why?
Inflammation
1
2016
674
0.100
 Why?
Pregnancy
1
2018
2620
0.100
 Why?
Signal Transduction
1
2017
1753
0.090
 Why?
Dysentery
1
2009
1
0.090
 Why?
Trichuriasis
1
2009
1
0.090
 Why?
Trichuris
1
2009
1
0.090
 Why?
Anesthesia, Intravenous
1
2008
13
0.080
 Why?
Eosinophils
1
2009
36
0.080
 Why?
Antineoplastic Agents
1
2017
1300
0.080
 Why?
Lipopeptides
1
2008
64
0.080
 Why?
Amyloidosis
1
2009
85
0.080
 Why?
Inflammatory Bowel Diseases
1
2009
57
0.080
 Why?
Tuberculosis
1
2009
104
0.080
 Why?
Candidiasis
1
2008
122
0.080
 Why?
Aspergillosis
1
2008
127
0.080
 Why?
Prospective Studies
2
2023
2604
0.070
 Why?
Kidney Diseases
1
2009
293
0.070
 Why?
Probability
1
2023
176
0.060
 Why?
Neuroimaging
1
2023
88
0.060
 Why?
Potassium Channels
1
2021
41
0.050
 Why?
Databases, Factual
1
2023
684
0.050
 Why?
Administration, Intravenous
1
2020
75
0.050
 Why?
Sleep Stages
1
2020
46
0.050
 Why?
Age of Onset
1
2020
117
0.050
 Why?
Cognition
1
2022
348
0.040
 Why?
Immunohistochemistry
1
2021
1089
0.040
 Why?
Internet
1
2013
275
0.020
 Why?
Software
1
2013
296
0.020
 Why?
Young Adult
1
2020
4318
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Mebendazole
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
7
0.020
 Why?
Antitubercular Agents
1
2009
90
0.020
 Why?
Colonoscopy
1
2009
105
0.020
 Why?
Prognosis
1
2009
2118
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (315) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (29) people
_
Same Department Expand Description
Search Department